Liriopesides B

CAS No. 87425-34-1

Liriopesides B( —— )

Catalog No. M19205 CAS No. 87425-34-1

Liriopesides B exhibited potential anticancer activity against human ovarian cancer A2780 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 In Stock
10MG 85 In Stock
25MG 147 In Stock
50MG 224 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Liriopesides B
  • Note
    Research use only, not for human use.
  • Brief Description
    Liriopesides B exhibited potential anticancer activity against human ovarian cancer A2780 cells.
  • Description
    Liriopesides B exhibited potential anticancer activity against human ovarian cancer A2780 cells.
  • In Vitro
    Liriopesides B (Nolinospiroside F) increases SIRT1 activity.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    87425-34-1
  • Formula Weight
    722.91
  • Molecular Formula
    C39H62O12
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (138.33 mM)
  • SMILES
    CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)OC7C(C(C(C(O7)C)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)C)OC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SXC 2023

    SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.

  • ABI-1968 PM

    ABI-1968 PM is a derivative of ABI-1968, an apoptosis-stimulating agent and an inhibitor of viral replication.

  • 3,7-Di-O-methylquerc...

    3,7-Di-O-methylquercetin shows α-glucosidase inhibition.